AYA Artrya Limited
Healthcare · Health Information Services
· website
$4.05
52wk 0.95 – 6.49
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Artrya Limited
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$662.48M
P/E (trailing)
—
P/E (forward)
-45.51
EPS (trailing)
-0.17
Dividend yield
—
Payout ratio
0.0%
Beta
0.59
EV / EBITDA
-26.65
Price / Book
7.17
ROE
-37.9%
Operating margin
-82,757.1%
Net margin
0.0%
Total cash
$76.67M
Total debt
$453,000
Current ratio
37.11
Debt / Equity
0.01
Free cash flow
$-16.18M
Avg volume
652,082
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$28.00K
- Gross profit$28.00K
- Operating income-$22.08M
- Net income-$16.41M
- Diluted EPS-0.18
- Free cash flow-$14.53M
- Net debt-$10.71M